Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Voyager Therapeut (NQ: VYGR ) 8.370 -0.060 (-0.71%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 227,640 Open 8.510 Bid (Size) 8.300 (20) Ask (Size) 9.450 (1) Prev. Close 8.430 Today's Range 8.315 - 8.633 52wk Range 6.060 - 11.72 Shares Outstanding 54,393,628 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 13, 2024 VYGR stock results show that Voyager Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing? April 17, 2024 Should you consider VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) for growth investing? Via Chartmill Performance YTD -7.00% -7.00% 1 Month +7.45% +7.45% 3 Month +10.71% +10.71% 6 Month +10.86% +10.86% 1 Year -10.19% -10.19% More News Read More The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio March 27, 2024 Via InvestorPlace Is NASDAQ:VYGR a Fit for Growth Investing Strategies? March 27, 2024 Via Chartmill Delving into NASDAQ:VYGR's Growth Prospects. March 26, 2024 Via Chartmill Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20 March 21, 2024 Via InvestorPlace Exploring NASDAQ:VYGR's growth characteristics. March 05, 2024 Via Chartmill Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing? March 05, 2024 Via Chartmill Voyager Therapeutics: Q4 Earnings Insights February 28, 2024 Via Benzinga Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform March 19, 2024 Via Benzinga Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge February 29, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket February 29, 2024 Via Benzinga Earnings Preview For Voyager Therapeutics February 27, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 29, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session February 28, 2024 Via Benzinga 7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff February 26, 2024 Via InvestorPlace 5 Value Stocks To Watch In The Healthcare Sector February 05, 2024 Via Benzinga Earnings Scheduled For February 28, 2024 February 28, 2024 Via Benzinga Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024 January 11, 2024 Via InvestorPlace A Look Into Healthcare Sector Value Stocks January 08, 2024 Via Benzinga Voyager Therapeutics stock pops 30% on deal with Novartis January 08, 2024 Via MarketBeat Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 05, 2024 Via Benzinga Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket January 05, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 05, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
